Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Orca Biosystems, Inc.
Orca Biosystems, Inc.
Boston Scientific Corporation
M.D. Anderson Cancer Center
Kura Oncology, Inc.
Cancer Research UK
Cancer Research UK
Genelux Corporation
Kelonia Therapeutics, Inc.
University of Pittsburgh
Turning Point Therapeutics, Inc.
University Health Network, Toronto
Azienda USL Reggio Emilia - IRCCS
Novartis